|
시장보고서
상품코드
2077829
자궁경부암 진단 검사 시장 : 검사 종류별, 연령층별, 지역별Cervical Cancer Diagnostic Tests Market, By Test Type, By Age Group, and By Region |
||||||
자궁경부암 진단 검사 시장은 2026년에 84억 7,000만 달러 규모가 될 것으로 추정되며, 2033년까지 131억 6,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 6.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 84억 7,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 6.50% | 2033년 시장 규모 예측: | 131억 6,000만 달러 |
자궁경부암은 자궁경부 표면에서 발생합니다. 이는 자궁경부 세포가 전암성 세포로 변하기 시작하면서 발생합니다. 자궁경부암에는 주로 '편평상피암'과 '선암'의 두 가지 종류가 있습니다. 자궁경부암의 약 80%에서 90%는 편평상피암이며, 10%에서 20%는 선암입니다. 물 같은 질 분비물이나 피가 섞인 질 분비물(양이 많아지거나 악취가 날 수 있음), 성관계 후 질 출혈, 생리 기간 외 또는 폐경 후의 질 출혈, 그리고 생리량이 늘어나거나 생리 기간이 평소보다 길어지는 것 등이 1기 자궁경부암의 징후나 증상으로 꼽힙니다. 자궁경부암의 대부분은 성병인 인유두종바이러스(HPV)에 의해 발생합니다. 인유두종바이러스(HPV)는 성행위(항문, 구강 또는 질)를 통해 감염되며, 암을 유발할 가능성이 있습니다. 대부분의 사람은 인생의 어느 시점에서 HPV에 감염되지만, 신체가 감염과 싸우기 때문에 이를 알아차리지 못하는 경우가 대부분입니다. 정기적인 부인과 검진을 받고, 자궁경부암 검진(파프 검사)을 받으며, 안전한 성관계를 실천하는 것이 자궁경부암 예방을 위해 취할 수 있는 가장 중요한 조치입니다. 자궁경부암의 주요 치료법으로는 수술, 방사선 치료, 화학요법이 있습니다. 자궁경부암 진단에는 파파니콜로 검사, 질확대경 검사, 자궁경관 소파술(ECC)이 시행됩니다. 신흥국에서 자궁경부암에 대한 인식이 높아지고, 자궁경부암 진단 연구 개발에 대한 자금 지원이 증가함에 따라, 예측 기간 동안 시장 성장을 견인할 것으로 전망됩니다.
시장 역학
예측 기간 동안 자궁경부암 발병률의 증가, 인유두종바이러스(HPV)에 감염된 환자 수의 증가, 그리고 10대 성 경험자의 증가로 인해 자궁경부암 진단 검사 세계 시장은 확대될 것으로 예상됩니다. 예를 들어, 2022년 2월 세계보건기구(WHO) 보고서에 따르면, 자궁경부암은 전 세계적으로 여성 암 중 4번째로 많이 발생하는 암이며, 2020년에는 약 60만 4,000건의 신규 환자와 34만 2,000명의 사망자가 보고되었습니다. 2020년 전 세계 신규 확진자 및 사망자의 약 90%는 아프가니스탄, 방글라데시, 인도, 중국 등 저·중소득 국가에서 발생했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 자궁경부암 진단 검사 시장의 주요 기업 개요을 소개하고 있습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 세계 자궁경부암 진단 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 자궁경부암 진단 검사 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 자궁경부암 진단 검사 시장 : 테스트 유형별, 2021-2033년
제5장 세계의 자궁경부암 진단 검사 시장 : 연령층별, 2021-2033년
제6장 세계의 자궁경부암 진단 검사 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSM 26.07.08Cervical Cancer Diagnostic Tests Market is estimated to be valued at USD 8.47 Bn in 2026 and is expected to reach USD 13.16 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.47 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.50% | 2033 Value Projection: | USD 13.16 Bn |
Cervical cancer, or cancer of the cervix, begins on the surface of your cervix. It happens when the cells on your cervix begin to change to precancerous cells. There are two main types of cancer of the cervix: squamous cell carcinomas and adenocarcinomas. About 80% to 90% of cervical cancers are squamous cell carcinomas, while 10% to 20% are adenocarcinomas. Watery or bloody vaginal discharge that may be heavy and can have a foul odor, vaginal bleeding after intercourse, between menstrual periods or after menopause and menstrual periods may be heavier and last longer than normal are some sign and symptoms of stage 1 cervical cancer. Most cervical cancers are caused by the virus HPV, a sexually transmitted infection. Human papillomavirus (HPV) spreads through sexual contact (anal, oral or vaginal) and can lead to cancer. Most people will get HPV at some point in their lives and not realize it because their bodies fight the infection. Receiving regular gynecological exams, getting Pap tests and practicing safe sex are the most important steps that you can take toward the prevention of cervical cancer. Surgery, radiation and chemotherapy are the main treatments for cervical cancer. Pap smear, colposcopy, and endocervical curettage (ECC) procedures are performed for the diagnosis of cervical cancer. Increasing awareness regarding cervical cancer in emerging economies and increasing funding for research and development in diagnosis of cervical cancer are expected to drive growth of the market during the forecast period.
Market Dynamics
Over the projected period, the global market for cervical cancer diagnostic tests is anticipated to increase due to the rising incidence of the disease, the high frequency of patients infected with the human papillomavirus (HPV), and the rising number of teenage sex experiences. For instance, in February 2022, according to the World Health Organization (WHO), Cervical cancer is the fourth most common cancer among women globally, with an estimated 604 000 new cases and 342 000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries such as Afghanistan, Bangladesh, India, China, etc.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cervical cancer diagnostic tests market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study are Guided Therapeutics, Inc., Abbott, Beckman Coulter, Inc., BD (Becton, Dickinson and Company), F. Hoffmann-La Roche Ltd, Bio Farma, Hologic, Inc., Oncgnostics GmbH, AstraZeneca, MobileODT, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., DYSIS Medical Inc., The Cooper Companies Inc., Danaher, Quest Diagnostics, Arbor Vita Corporation, and Zilico.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global cervical cancer diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical cancer diagnostic tests market
Detailed Segmentation:
- Global Cervical Cancer Diagnostic Tests Market, By Test Type (Revenue, USD Bn, 2021 - 2033)
- Pap Smear Test
- Colposcopy Test
- Endocervical curettage Test
- HPV Test
- Global Cervical Cancer Diagnostic Tests Market, By Age Group:
- Age 20-40
- Age above 40
- Global Cervical Cancer Diagnostic Tests Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Guided Therapeutics, Inc
- Abbott
- Beckman Coulter, Inc.
- BD (Becton, Dickinson and Company)
- Hoffmann-La Roche Ltd
- Bio Farma
- FinVector Vision Therapies
- Hologic, Inc.
- Oncgnostics GmbH
- AstraZeneca
- MobileODT
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- DYSIS Medical Inc.
- The Cooper Companies Inc.
- Danaher
- Quest Diagnostics
- Arbor Vita Corporation
- Zilico
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Age Group
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Regulatory Guideline and Compliances
- Epidemiology
- Pricing Analysis
- Key Developments
- PEST Analysis
- PORTER's Analysis
4. Global Cervical Cancer Diagnostic Tests Market, By Test Type, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Pap Smear Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Colposcopy Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Endocervical curettage Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- HPV Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
5. Global Cervical Cancer Diagnostic Tests Market, By Age Group, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segments Trends
- Age 20-40
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Age above 40
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
6. Global Cervical Cancer Diagnostic Tests Market, By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Guided Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BD (Becton, Dickinson and Company)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F.Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio Farma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Oncgnostics GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MobileODT
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DYSIS Medical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- The Cooper Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Arbor Vita Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zilico
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
